TY - JOUR
T1 - Genotype Predicts Outcomes in Fetuses and Neonates With Severe Congenital Long QT Syndrome
AU - Moore, Jeremy P.
AU - Gallotti, Roberto G.
AU - Shannon, Kevin M.
AU - Bos, J. Martijn
AU - Sadeghi, Elham
AU - Strasburger, Janette F.
AU - Wakai, Ronald T.
AU - Horigome, Hitoshi
AU - Clur, Sally Ann
AU - Hill, Allison C.
AU - Shah, Maully J.
AU - Behere, Shashank
AU - Sarquella-Brugada, Georgia
AU - Czosek, Richard
AU - Etheridge, Susan P.
AU - Fischbach, Peter
AU - Kannankeril, Prince J.
AU - Motonaga, Kara
AU - Landstrom, Andrew P.
AU - Williams, Matthew
AU - Patel, Akash
AU - Dagradi, Federica
AU - Tan, Reina B.
AU - Stephenson, Elizabeth
AU - Krishna, Mani Ram
AU - Miyake, Christina Y.
AU - Lee, Michelle E.
AU - Sanatani, Shubhayan
AU - Balaji, Seshadri
AU - Young, Ming Lon
AU - Siddiqui, Saad
AU - Schwartz, Peter J.
AU - Shivkumar, Kalyanam
AU - Ackerman, Michael J.
N1 - Funding Information:
Dr. Strasburger has received support from the National Institutes of Health grant RO1HL143485. Dr. Wakai has received support from the National Institutes of Health grant RO1HL063174. Dr. Miyake has received support from the National Heart, Lung, and Blood Institute grant K23HL136932 and American Heart Association grant 17SDG33410183. Dr. Schwartz has received support from the National Institutes of Health grant HL083374 and Italian Ministry of Health grant (Sindrome della morte improvvisa del lattante: meccanismi e prevenzione). All other authors have reported that they have no relationships relevant to the contents of this paper to disclose. Samuel Viskin, MD, served as Guest Editor for this paper. Katja Zeppenfeld, MD, served as Guest Editor-in-Chief for this paper.
Publisher Copyright:
© 2020
PY - 2020/11
Y1 - 2020/11
N2 - Objectives: This study sought to determine the relationship between long QT syndrome (LQTS) subtype (LTQ1, LTQ2, LTQ3) and postnatal cardiac events (CEs). Background: LQTS presenting with 2:1 atrioventricular block or torsades de pointes in the fetus and/or neonate has been associated with risk for major CEs, but overall outcomes and predictors remain unknown. Methods: A retrospective study involving 25 international centers evaluated the course of fetuses/newborns diagnosed with congenital LQTS and either 2:1 atrioventricular block or torsades de pointes. The primary outcomes were age at first CE after dismissal from the newborn hospitalization and death and/or cardiac transplantation during follow-up. CE was defined as aborted cardiac arrest, appropriate shock from implantable cardioverter-defibrillator, or sudden cardiac death. Results: A total of 84 fetuses and/or neonates were identified with LQTS (12 as LQT1, 35 as LQT2, 37 as LQT3). Median gestational age at delivery was 37 weeks (interquartile range: 35 to 39 weeks) and age at hospital discharge was 3 weeks (interquartile range: 2 to 5 weeks). Fetal demise occurred in 2 and pre-discharge death in 1. Over a median of 5.2 years, there were 1 LQT1, 3 LQT2, and 23 LQT3 CEs (13 aborted cardiac arrests, 5 sudden cardiac deaths, and 9 appropriate shocks). One patient with LQT1 and 11 patients with LQT3 died or received cardiac transplant during follow-up. The only multivariate predictor of post-discharge CEs was LQT3 status (LQT3 vs. LQT2: hazard ratio: 8.4; 95% confidence interval: 2.6 to 38.9; p < 0.001), and LQT3, relative to LQT2, genotype predicted death and/or cardiac transplant (p < 0.001). Conclusions: In this large multicenter study, fetuses and/or neonates with LQT3 but not those with LQT1 or LQT2 presenting with severe arrhythmias were at high risk of not only frequent, but lethal CEs.
AB - Objectives: This study sought to determine the relationship between long QT syndrome (LQTS) subtype (LTQ1, LTQ2, LTQ3) and postnatal cardiac events (CEs). Background: LQTS presenting with 2:1 atrioventricular block or torsades de pointes in the fetus and/or neonate has been associated with risk for major CEs, but overall outcomes and predictors remain unknown. Methods: A retrospective study involving 25 international centers evaluated the course of fetuses/newborns diagnosed with congenital LQTS and either 2:1 atrioventricular block or torsades de pointes. The primary outcomes were age at first CE after dismissal from the newborn hospitalization and death and/or cardiac transplantation during follow-up. CE was defined as aborted cardiac arrest, appropriate shock from implantable cardioverter-defibrillator, or sudden cardiac death. Results: A total of 84 fetuses and/or neonates were identified with LQTS (12 as LQT1, 35 as LQT2, 37 as LQT3). Median gestational age at delivery was 37 weeks (interquartile range: 35 to 39 weeks) and age at hospital discharge was 3 weeks (interquartile range: 2 to 5 weeks). Fetal demise occurred in 2 and pre-discharge death in 1. Over a median of 5.2 years, there were 1 LQT1, 3 LQT2, and 23 LQT3 CEs (13 aborted cardiac arrests, 5 sudden cardiac deaths, and 9 appropriate shocks). One patient with LQT1 and 11 patients with LQT3 died or received cardiac transplant during follow-up. The only multivariate predictor of post-discharge CEs was LQT3 status (LQT3 vs. LQT2: hazard ratio: 8.4; 95% confidence interval: 2.6 to 38.9; p < 0.001), and LQT3, relative to LQT2, genotype predicted death and/or cardiac transplant (p < 0.001). Conclusions: In this large multicenter study, fetuses and/or neonates with LQT3 but not those with LQT1 or LQT2 presenting with severe arrhythmias were at high risk of not only frequent, but lethal CEs.
KW - atrioventricular block
KW - cardiac sympathetic denervation
KW - fetal arrhythmia
KW - fetus
KW - genetic testing
KW - implantable cardioverter-defibrillator
KW - long QT syndrome
KW - magnetocardiography
KW - sudden cardiac death
KW - torsades de pointes
UR - http://www.scopus.com/inward/record.url?scp=85090485030&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85090485030&partnerID=8YFLogxK
U2 - 10.1016/j.jacep.2020.06.001
DO - 10.1016/j.jacep.2020.06.001
M3 - Article
C2 - 33213816
AN - SCOPUS:85090485030
SN - 2405-5018
VL - 6
SP - 1561
EP - 1570
JO - JACC: Clinical Electrophysiology
JF - JACC: Clinical Electrophysiology
IS - 12
ER -